Journal of Aerosol Medicine and Pulmonary Drug Delivery

Papers
(The TQCC of Journal of Aerosol Medicine and Pulmonary Drug Delivery is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
The Effect of Different Interfaces on the Aerosol Delivery with Vibrating Mesh Nebulizer During Noninvasive Positive Pressure Ventilation30
Inhaled Nanoparticulate Systems: Composition, Manufacture and Aerosol Delivery21
Feasibility and Initial Safety Evaluation of Inhaled 13C-Urea in Ambulatory Patients with Pneumonia20
Fine Particle Fraction: The Good and the Bad19
Pressure Drop Characteristics of the Reduced NGI Configuration with Several Common Glass Fiber Filters19
Minimizing Aerosol Leakage from Facemasks in the COVID-19 Pandemic19
Delivery of Dihydroergotamine Mesylate to the Upper Nasal Space for the Acute Treatment of Migraine: Technology in Action18
Dry Powder Inhalers: From Bench to Bedside16
Suitability of Bronchoscopic Spraying for Fluid Deposition in Lower Airway Regions: Fluorescence Analysis on a Transparent In Vitro Airway Model14
Abstract Author Indexby abstract number12
Abstracts from The International Society for Aerosols in Medicine 23rd ISAM Congress Boise, Idaho May 22–26, 202111
An Investigation into the Factors Associated with Incorrect Use of a Pressurized Metered-Dose Inhaler in Japanese Patients11
Are the Reference Values for the Provocative Concentration of Methacholine Appropriate for Children?10
In Vitro Effect of Combined Hypertonic Saline and Salbutamol on Ciliary Beating Frequency and Mucociliary Transport in Human Nasal Epithelial Cells of Healthy Volunteers and Patients with Cysti10
Pharmaceutical, Clinical, and Regulatory Challenges of Reformulating Pressurized Metered-Dose Inhalers to Reduce Their Environmental Impact10
Rosalind Franklin Society Proudly Announces the 2022 Award Recipient for Journal of Aerosol Medicine and Pulmonary Drug Delivery10
Developing Dry Powder Inhaler Formulations9
Imaging Aerosol Deposition with Two-Dimensional Gamma Scintigraphy9
Optimal Inhalation Profile of Pressurized Metered Dry Powder Inhaler Using a Valved Holding Chamber: A Dynamic Analysis8
In Vitro Performance of the Wixela Inhub Inhaler Using Severe Chronic Obstructive Pulmonary Disease Patient Inhalation Profiles8
The Unfulfilled Promise of Inhaled Therapy in Ventilator-Associated Infections: Where Do We Go from Here?7
Heterogenous Intrapulmonary Distribution of Aerosolized Model Compounds in Mice with Bleomycin-Induced Pulmonary Fibrosis7
A Phase I Study of TRK-250, a Novel siRNA-Based Oligonucleotide, in Patients with Idiopathic Pulmonary Fibrosis7
Building on Strong Foundations: The Next Chapter in the Story of the Journal of Aerosol Medicine and Pulmonary Drug Delivery7
Inhalation Pharmacodynamics6
Nebulizers6
Inhaled Nitric Oxide in Acute Respiratory Distress Syndrome Subsets: Rationale and Clinical Applications5
Safety, Tolerability, and Pharmacokinetics of RT234 (Vardenafil Inhalation Powder): A First-in-Human, Ascending Single- and Multiple-Dose Study in Healthy Subjects5
The Effects of Inspiratory Flows, Inspiratory Pause, and Suction Catheter on Aerosol Drug Delivery with Vibrating Mesh Nebulizers During Mechanical Ventilation5
Safety and Efficacy of 2.5 mg and 1.25 mg Nebulized Salbutamol Compared with Placebo on Transient Tachypnea of the Newborns: A Triple-Blind Phase II/III Parallel Randomized Controlled Trial5
Inspiratory Profiles Through Easyhaler Dry Powder Inhaler During Acute Bronchoconstriction5
Practical Considerations in Dose Extrapolation from Animals to Humans5
Multidrug Aerosol Delivery During Mechanical Ventilation5
Abstract Author Index5
Pressurized Metered Dose Inhaler Aerosol Delivery Within Nasal High-Flow Circuits: A Bench Study5
Overview of Inhaled Nanopharmaceuticals4
Barriers that Inhaled Particles Encounter4
Results of Tobramycin Inhalation Therapy in Patients with Noncystic Fibrosis Bronchiectasis with Pseudomonas aeruginosa Colonization: Real Life Management4
How Cold Is Cold Enough? Refrigeration of the Next-Generation Impactor to Prevent Aerosol Undersizing4
Acknowledgment of Reviewers 20214
Spray Drying and Particle Engineering in Dosage Form Design for Global Vaccines4
In Vitro Drug Delivery of a Fixed-Dose Combination of Fluticasone Furoate/Umeclidinium/Vilanterol from a Dry Powder Inhaler4
Changes in Peak Inspiratory Flow After Acute Bronchodilation: An Observational Study of Patients with Stable Chronic Obstructive Pulmonary Disease3
Aerosol Delivery to an Adult Model via High-Flow Nasal Cannula with Inspiration-Synchronized Small-Particle Vibrating Mesh Nebulizer3
The Association of Inhaled Corticosteroid Before Admission and Survival of Patients with COVID-193
Lung Deposition of Inhaled Extrafine Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium Bromide in Healthy Volunteers and Asthma: The STORM Study3
Targeting Immune Cells3
Magnetic Resonance Imaging of Aerosol Deposition3
Quantifying Exhaled Particles in Healthy Humans During Various Respiratory Activities Under Realistic Conditions3
Comparison of Intranasal Steroid Application Using Nasal Saline Irrigation and a Mucosal Atomization Device to Treat Chronic Rhinosinusitis3
Optimal Inhalation Flow Pattern from Turbuhaler Predicted by Laser Photometry3
In Vitro Comparison of Inspiration-Synchronized and Continuous Vibrating Mesh Nebulizer During Adult Invasive Mechanical Ventilation3
Comparison of Vibrating Mesh and Jet Nebulizers During Noninvasive Ventilation in Acute Exacerbation of Chronic Obstructive Pulmonary Disease3
The Use of Aerosolized Medications in Adult Intensive Care Unit Patients: A Prospective, Multicenter, Observational, Cohort Study3
Acknowledgment of Reviewers 20233
Acceptance Testing of Used Cascade Impactor Stages Based on Pressure Drop Measurements in a Flow System Managed with a Critical Flow Venturi: Part I—Laboratory Proof-of-Principle3
Sodium Pyruvate Nasal Spray Reduces the Severity of Nasal Inflammation and Congestion in Patients with Allergic Rhinitis3
0.13534092903137